MedPath

Comparison between the effect of oral chloral hydrate and intranasal dexmedetomidine on pediatric sedation for EEG

Phase 3
Recruiting
Conditions
Sedation.
Registration Number
IRCT20180520039739N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with age of 3 month to 3 years
Patients who need EEG
patients with ASA1,ASA2

Exclusion Criteria

Sensitivity to dexmedetomidine or chloral hydrate in past medical histoty

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: In One houre. Method of measurement: Ramsy score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath